Status:
UNKNOWN
The Use of Peripheral Blood Specimens From Patients Suspected of Having SARS-CoV-2 Infections in Research Studies Intended to Support the Development of COVID-19 Detection Methods, Treatments, and/or Vaccines
Lead Sponsor:
Invivoscribe, Inc.
Conditions:
SARS-CoV-2
Eligibility:
All Genders
Brief Summary
Invivoscribe, Inc. and its wholly owned subsidiary LabPMM, LLC are collecting peripheral blood specimens from patients with suspected SARS-CoV-2 viral infections. These donors will be from a populatio...
Detailed Description
This research protocol describes the collection and analysis of peripheral blood samples to: * Identify nucleic acid sequences that may be used aide in the development of SARSCoV- 2 detection methods...
Eligibility Criteria
Inclusion
- From patients suspected of SARS-CoV-2 viral infections.
- From patients who have had COVID-19 testing prescribed by their treating physicians.
- From patients whose COVID-19 test specimen was sent to LabPMM, LLC for testing
Exclusion
- There are no exclusion criteria related to age, gender, race, ethnicity, geography, and/or other medical conditions.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2021
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04391400
Start Date
June 1 2020
End Date
June 30 2021
Last Update
May 18 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.